Robust physical methods that enrich genomic regions identical by descent for linkage studies: confirmation of a locus for osteogenesis imperfecta

Brooks, Peter; Marcaillou, Charles; Vanpeene, Maud; Saraiva, Jean-Paul; Stockholm, Daniel; Francke, Stephan; Favis, Reyna; Cohen, Nadine; Rousseau, Francis; Tores, Frédéric; Lindenbaum, Pierre; Hager, Jörg; Philippi, Anne
January 2009
BMC Genetics;2009, Vol. 10, Special section p1
Academic Journal
Background: The monogenic disease osteogenesis imperfecta (OI) is due to single mutations in either of the collagen genes ColA1 or ColA2, but within the same family a given mutation is accompanied by a wide range of disease severity. Although this phenotypic variability implies the existence of modifier gene variants, genome wide scanning of DNA from OI patients has not been reported. Promising genome wide marker-independent physical methods for identifying diseaserelated loci have lacked robustness for widespread applicability. Therefore we sought to improve these methods and demonstrate their performance to identify known and novel loci relevant to OI. Results: We have improved methods for enriching regions of identity-by-descent (IBD) shared between related, afflicted individuals. The extent of enrichment exceeds 10- to 50-fold for some loci. The efficiency of the new process is shown by confirmation of the identification of the Col1A2 locus in osteogenesis imperfecta patients from Amish families. Moreover the analysis revealed additional candidate linkage loci that may harbour modifier genes for OI; a locus on chromosome 1q includes COX-2, a gene implicated in osteogenesis. Conclusion: Technology for physical enrichment of IBD loci is now robust and applicable for finding genes for monogenic diseases and genes for complex diseases. The data support the further investigation of genetic loci other than collagen gene loci to identify genes affecting the clinical expression of osteogenesis imperfecta. The discrimination of IBD mapping will be enhanced when the IBD enrichment procedure is coupled with deep resequencing.


Related Articles

  • Genotype–phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I. Rauch, Frank; Lalic, Liljana; Roughley, Peter; Glorieux, Francis H. // European Journal of Human Genetics;Jun2010, Vol. 18 Issue 6, p642 

    Osteogenesis imperfecta (OI) is a heritable disorder with bone fragility that is often associated with short stature, tooth abnormalities (dentinogenesis imperfecta), and blue sclera. The most common mutations associated with OI result from the substitution for glycine by another amino acid in...

  • A Missense Mutation in the SERPINH1 Gene in Dachshunds with Osteogenesis Imperfecta. Drögemüller, Cord; Becker, Doreen; Brunner, Adrian; Haase, Bianca; Kircher, Patrick; Seeliger, Frank; Fehr, Michael; Baumann, Ulrich; Lindblad-Toh, Kerstin; Leeb, Tosso // PLoS Genetics;Jul2009, Vol. 5 Issue 7, p1 

    Osteogenesis imperfecta (OI) is a hereditary disease occurring in humans and dogs. It is characterized by extremely fragile bones and teeth. Most human and some canine OI cases are caused by mutations in the COL1A1 and COL1A2 genes encoding the subunits of collagen I. Recently, mutations in the...

  • Bone Collagen: New Clues to Its Mineralization Mechanism from Recessive Osteogenesis Imperfecta. Eyre, David; Weis, Mary // Calcified Tissue International;Oct2013, Vol. 93 Issue 4, p338 

    Until 2006 the only mutations known to cause osteogenesis imperfecta (OI) were in the two genes coding for type I collagen chains. These dominant mutations affecting the expression or primary sequence of collagen α1(I) and α2(I) chains account for over 90 % of OI cases. Since then a...

  • Lack of Cyclophilin B in Osteogenesis Imperfecta with Normal Collagen Folding. Barnes, Aileen M.; Carter, Erin M.; Cabral, Wayne A.; Weis, MaryAnn; Chang, Weizhong; Makareeva, Elena; Leikin, Sergey; Rotimi, Charles N.; Eyre, David R.; Raggio, Cathleen L.; Marini, Joan C. // New England Journal of Medicine;2/11/2010, Vol. 362 Issue 6, p521 

    Osteogenesis imperfecta is a heritable disorder that causes bone fragility. Mutations in type I collagen result in autosomal dominant osteogenesis imperfecta, whereas mutations in either of two components of the collagen prolyl 3-hydroxylation complex (cartilage-associated protein [CRTAP] and...

  • Uwarunkowania genetyczne wrodzonej Å‚amliwoÅ›ci koÅ›ci - przeglÄ…d aktualnego piÅ›miennictwa. Beska, Karolina; Rusińska, Agnieszka; Michałus, Izabela; Chlebna-Sokół, Danuta // Pediatric Endocrinology / Endokrynologia Pediatryczna;2014, Vol. 13 Issue 3, p57 

    Osteogenesis imperfecta is a rare, genetically conditioned disease of connective tissue. Clinical symptoms of disease come from abnormal structure or inadequate amount of collagen in bone tissue. The most common causes of osteogenesis imperfecta are mutations in COL1A1 and COL1A2 genes, encoding...

  • RNAi of COL1A1 in mesenchymal progenitor cells. Millington-Ward, Sophia; McMahon, Helena P; Allen, Danny; Tuohy, Gearóid; Kiang, Anna-Sophia; Palfi, Arpad; Kenna, Paul F.; Humphries, Peter; Farrar, G. Jane // European Journal of Human Genetics;Oct2004, Vol. 12 Issue 10, p864 

    Given that mutant COL1A1 is known to cause Osteogenesis Imperfecta (OI), tools to modulate COL1A1 expression are likely to be of significant therapeutic value. In this context, we have evaluated RNA interference (RNAi) as a means to downregulate COL1A1 expression in Cos-7 cells and in human...

  • Identification of gene mutation in patients with osteogenesis imperfect using high resolution melting analysis. Wang, Jianhai; Ren, Xiuzhi; Bai, Xue; Zhang, Tianke; Wang, Yi; Li, Keqiu; Li, Guang // Scientific Reports;8/28/2015, p13468 

    Osteogenesis imperfecta (OI), a congenital bone disorder, is caused by mutations in COL1A1 and COL1A2 genes, leading to deficiency of type I collagen. The high resolution melting (HRM) analysis has been used for detecting mutations, polymorphisms and epigenetic alteration in double-stranded...

  • Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients. Rauch, Frank; Moffatt, Pierre; Cheung, Moira; Roughley, Peter; Lalic, Liljana; Lund, Allan M.; Ramirez, Norman; Fahiminiya, Somayyeh; Majewski, Jacek; Glorieux, Francis H. // Journal of Medical Genetics;Jan2013, Vol. 50 Issue 1, p21 

    Background Osteogenesis imperfecta (OI) type V is an autosomal dominant bone fragility disorder that we had described a decade ago. Recent research has shown that OI type V is caused by a recurrent c.-14C>T mutation in IFITM5. In the present study, we assessed all patients diagnosed with OI type...

  • Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defects. Pochampally, R. R.; Horwitz, E. M.; DiGirolamo, C. M.; Stokes, D. S.; Prockop, D. J. // Gene Therapy;Jul2005, Vol. 12 Issue 14, p1119 

    Gene therapy for dominant-negative disorders presents a more difficult challenge than gene therapy for recessive disorders, since even partial replacement of a protein for a recessive disorder can reverse symptoms. Osteogenesis imperfecta (OI) has frequently served as a model disorder for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics